BUY-SIDE ADVISORY

HGP begins each buy-side assignment with an intensive strategic review process designed to align the acquisition strategy with long-term shareholder objectives. Following completion of the initial strategic review, market assessment, and market mapping, HGP executes on the vision by identifying and pursuing acquisition targets. HGP dynamically reevaluates and refreshes the acquisition and strategic vision based on discovery from the process itself, which may be utilized to position a buyer for its own future liquidity event. HGP has experienced high success rates in identifying and closing proprietary transactions that achieve objectives of both the buyer and seller, resulting in strong returns for our clients.

HGP Buy-Side Advisory Process

Related Research & News Articles

The Tension Between Healthcare Pricing and Consumerism

Read More

HGP Releases its Mid-Year Health IT Market Review

Read More

Demystifying the Pharmaceutical Supply Chain

Read More

Valuations Round 2: Health IT SaaS vs Health IT Non-SaaS

Read More